Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Thymidine Phosphorylase Gene Mutations in MNGIE, a Human Mitochondrial Disorder

Ichizo Nishino, Antonella Spinazzola and Michio Hirano
Science
New Series, Vol. 283, No. 5402 (Jan. 29, 1999), pp. 689-692
Stable URL: http://www.jstor.org/stable/2897562
Page Count: 4
  • More info
  • Cite this Item
Thymidine Phosphorylase Gene Mutations in MNGIE, a Human Mitochondrial Disorder
Preview not available

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive human disease associated with multiple deletions of skeletal muscle mitochondrial DNA (mtDNA), which have been ascribed to a defect in communication between the nuclear and mitochondrial genomes. Examination of 12 MNGIE probands revealed homozygous or compound-heterozygous mutations in the gene specifying thymidine phosphorylase (TP), located on chromosome 22q13.32-qter. TP activity in leukocytes from MNGIE patients was less than 5 percent of controls, indicating that loss-of-function mutations in TP cause the disease. The pathogenic mechanism may be related to aberrant thymidine metabolism, leading to impaired replication or maintenance of mtDNA, or both.

Page Thumbnails

  • Thumbnail: Page 
689
    689
  • Thumbnail: Page 
690
    690
  • Thumbnail: Page 
691
    691
  • Thumbnail: Page 
692
    692